The FDA approved clesrovimab (Enflonsia) to prevent lower respiratory tract disease from respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, drugmaker Merck ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring its effectiveness, according to Yale research published in JAMA Network Open.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Health Canada has approved ENFLONSIA® (clesrovimab) for ...

Pediatricians at Penn State Health Golisano Children’s Hospital are seeing cases of the flu, RSV, strep throat, seasonal allergies, croup and viral upper respiratory infections. Dr. Leah Kaye, ...

This is read by an automated voice. Please report any issues or inconsistencies here. The leading cause of infant hospitalization, RSV can trigger severe pneumonia and lung infections. Health ...

RSV might sound like just another cold virus, but for babies and young kids, it can turn serious fast. Here's what you need to know to spot it early, manage symptoms, and keep your tiny CEO safe. RSV ...

Pediatricians at Penn State Health Golisano Children’s Hospital are seeing flu, strep throat, ear infections, RSV and ...

RSV is a common contagious virus that infects the human respiratory tract. Here: scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) that are labeled with ...

RSV vaccination in older adults significantly reduced cases of lower respiratory tract disease and deaths, with updated recommendations for high-risk groups. Nirsevimab effectively reduced ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Julia Naftulin Every time Julia publishes a story, you’ll get an alert straight to your inbox!